Search
Kyverna Therapeutics Inc
KYTXAdd to Watchlist
6.990USD
-0.080-1.13%
Close 09-24 16:00（ET）
424.99MMarket Cap
LossP/E TTM
KYTX Financials
See Kyverna Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
424.99M
Dividend TTM
0.00
P/E TTM
-2.14
EPS TTM
-3.27
Revenue
--
Net Profit
-127.48M
ROE
-74.55%
ROA
-60.42%
Kyverna Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.63/-0.68
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What are the current assets of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its current assets were 282.95M, with a year-on-year change of -2.63.
What are the total assets of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its total assets of Kyverna Therapeutics Inc were 293.83M, with a year-on-year change of -3.55.
What are the total liabilities of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its total liabilities of Kyverna Therapeutics Inc were 61.55M, with a year-on-year change of 61.73.
What is the total equity of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its total equity of Kyverna Therapeutics Inc was 232.28M, with a year-on-year change of -12.87.
What is the net operating income of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its net operating income of Kyverna Therapeutics Inc was -169.23M, with a year-on-year change of -18.67.
What is the net investment of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its net investment of Kyverna Therapeutics Inc was 40.02M, with a year-on-year change of 124.87.
What is the net financing of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its net financing of Kyverna Therapeutics Inc was 141.17M, with a year-on-year change of -58.12.
What is the Earnings Per Share (EPS) of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.64, with a year-on-year change of -9.60.
What is the net income of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its net income was -161.31M, with a year-on-year change of -26.54.
What is the debt-to-asset ratio of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 8.53, with a year-on-year change of 2720.10.
What is the Return on Equity (ROE) of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -64.67, with a year-on-year change of 65.71.
What is the Return on Assets (ROA) of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -53.91, with a year-on-year change of 19.69.
What is the operating profit of Kyverna Therapeutics Inc?
According to Kyverna Therapeutics Inc's FY2025 earnings report, its operating profit was -169.23M, with a year-on-year change of -18.67.